ReInnervate
ReInnervate is a biotechnology company specialising in the development of enabling technologies for use in research into cell growth and function and are developing novel approaches to monitor and control cell differentiation with distinct applications in stem cell biology.
The development of its patented technology for three-dimensional cell growth is ready to go into production and to market, and this is considered low risk;
Its programme to design and synthesise synthetic compounds to control cell differentiation is well advanced. The characterisation of several new candidate molecules is nearing completion, and this is low-medium risk;
Its technology for the identification and development of biomarkers to follow cell differentiation is at an earlier stage and is therefore of higher risk but is potentially of significant commercial value.
Each of these technologies has a defined market. As the field of stem cell biology continues to progress, the demand for enabling technologies, such as those under development by ReInnervate, will significantly increase and further enhance their commercial value.
Contact:
stefan.przyborski@dur.ac.uk